Moderna
MRNA
MRNA
1,001 hedge funds and large institutions have $42.7B invested in Moderna in 2022 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 401 increasing their positions, 325 reducing their positions, and 221 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,001
Holders Change
-103
Holders Change %
-9.33%
% of All Funds
15.84%
Holding in Top 10
23
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.55%
% of All Funds
0.36%
New
132
Increased
401
Reduced
325
Closed
221
Calls
$6.98B
Puts
$3.71B
Net Calls
+$3.27B
Net Calls Change
+$5.16B
Top Buyers
| 1 |
Coatue Management
New York
|
$1.19B |
| 2 |
Renaissance Technologies
New York
|
$658M |
| 3 |
TP
Theleme Partners
London,
United Kingdom
|
$1.09B |
| 4 |
BlackRock
New York
|
$4.94B |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$311M |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
$226M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$387M |
| 3 |
Morgan Stanley
New York
|
$501M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
$140M |
| 5 |
Jane Street
New York
|
$111M |
